At the news
? NEUTRALIMPACT 3/10 144 filed Nov 3, 2026 at 10:10 ET
Catherine T. Doherty, an officer of Quest Diagnostics, filed a Form 144 notice of intent to sell 22,105 shares of common stock, valued at approximately $5.58 million based on the filing date. The shares were acquired through a stock option exercise on the same day. The sale is a routine insider transaction following option exercise, but the size is notable relative to recent insider activity.
- Reporting owner: Catherine T. Doherty, an officer of Quest Diagnostics
- Proposed sale: 22,105 shares of common stock
- Approximate value: $5,584,607.20 (based on filing date price)
- Shares acquired via stock option exercise on 11/03/2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access